T. Caruso

Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience

P. Migliorini, S. Galimberti, F. Pratesi, 2022, Clinical and Experimental Medicine.

AB1152 COVID-19 mRNA VACCINE BOOSTER IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

L. Gualtieri, R. Talarico, C. Tani, 2022, Annals of the Rheumatic Diseases.

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers

David V. Gioe, P. Migliorini, F. Pratesi, 2021, Vaccines.

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

P. Migliorini, G. Masi, F. Salani, 2023, International Journal of Clinical Oncology.

Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience

P. Migliorini, S. Galimberti, F. Pratesi, 2022, Clinical and Experimental Medicine.